Drug hypersensitivity and eosinophilia: The decisive role of p‐i stimulation
Allergy · 2023
DOI: 10.1111/all.15795 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, 2023. Verfasst von Werner J Pichler und 2 weiteren Autor:innen. Beteiligte Einrichtung: ADR-AC GmbH, Bern, Switzerland. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Eosinophilia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Eosinophilia is a common finding in drug hypersensitivity reactions (DHR). Its cause is unclear, as neither antigen/allergen‐driven inflammation nor clonal expansion is involved. Most delayed‐DHRs are due to p‐i ( p harmacologic interaction of drugs with i mmune receptors). These are off‐target activities of drugs with immune receptors that result in various types of T‐cell stimulation, some of which involve excessive IL‐5 production. Functional and phenotypic studies of T‐cell clones and their TCR‐transfected hybridoma cell lines revealed that some p‐i‐induced drug stimulations occur without CD4/ CD8 co‐receptor engagement. The CD4/CD8 co‐receptors link Lck (lymphocyte‐specific protein tyrosine kinase) and LAT (linker for activation of T cells) to the TCR. Alteration of Lck or LAT can result in a TCR signalosome with enhanced IL‐5 production. Thus, if a more affine TCR‐[drug/peptide/HLA] interaction allows bypassing the CD4 co‐receptor, a modified Lck/LAT activation may lead to a TCR signalosome with elevated IL‐5 production. This “IL‐5‐TCR‐signalosome” hypothesis could also explain eosinophilia in superantigen or allo‐stimulation (graft‐versus‐host disease), in which evasion of CD4/CD8 co‐receptors has also been described. It may open new therapeutic possibilities in certain eosinophilic diseases by directly targeting the IL‐5‐TCR signalosome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ADR-AC GmbH, Bern, Switzerland.
ORCID-Profile: Werner J Pichler, Lester Thoo, Daniel Yerly
Zitieren
APA
Pichler, W. J., Thoo, L., & Yerly, D. (2023). Drug hypersensitivity and eosinophilia: The decisive role of p‐i stimulation. Allergy. https://doi.org/10.1111/all.15795
Vancouver
Pichler WJ, Thoo L, Yerly D. Drug hypersensitivity and eosinophilia: The decisive role of p‐i stimulation. Allergy. 2023. doi:10.1111/all.15795
BibTeX
@article{Pichler2023,
author = {Pichler, Werner J and Thoo, Lester and Yerly, Daniel},
title = {Drug hypersensitivity and eosinophilia: The decisive role of p‐i stimulation},
journal = {Allergy},
year = {2023},
doi = {10.1111/all.15795}
}
EUVIMED